Cronos Australia Limited announced that it intended to launch additional Adaya products in the coming months, including the new Adaya 25:25 THC:CBD-balanced Medicinal Cannabis Oil in a 50ml tincture, with an expected launch in November 2021. This product will assist in the on-going treatment of new and established patients who require a higher strength and balanced product. Adaya 25:25 will be sold at an affordable price per milligram of active ingredient, underpinning the importance of accessibility to Adaya products for consumers. The expanded Adaya range will comprise the following 8 products: Adaya THC 30 ­ THC-dominant Medicinal Cannabis Whole Flower (10-gram pack); Adaya THC 19 ­ THC-dominant Medicinal Cannabis Whole Flower (10-gram pack); Adaya 1:25 ­ CBD-dominant Medicinal Cannabis Oil (30ml tincture); Adaya CBD 100 ­ CBD-only Medicinal Cannabis Oil (30ml tincture); Adaya 20:1 ­ THC-dominant Medicinal Cannabis Oil (30ml tincture); Adaya THC 26 ­ THC-only Medicinal Cannabis Oil (50ml tincture); Adaya 10:10 ­ THC:CBD-balanced Medicinal Cannabis Oil (30ml tincture); Adaya 25:25 ­ THC:CBD-balanced Medicinal Cannabis Oil (50ml tincture). All Adaya products, have been specifically developed based on feedback from Australian patients and healthcare professionals, with all products being: Australian-Grown (excluding the Adaya CBD 100); Australian-Manufactured to GMP standards; Value-priced, to prioritise patient accessibility and affordability; and Widely available through distributors and pharmacies nationwide to ensure no stock outs, which could negatively impact patients treatment and experience with the product.